Phlox Therapeutics

Description

Phlox Therapeutics develops precision RNA-based therapies to treat rare genetic cardiomyopathies, creating therapeutic candidates and collaborations to deliver RNA medicines to the heart for patient benefit.

Phlox Therapeutics is located in the Netherlands ecosystem.

Related

• Jazz PharmaceuticalsJazz Pharmaceuticals develops and commercializes medicines for people with rare diseases, focusing on therapies for epilepsies, cancers and…
• CircioCircio develops circular RNA and immunotherapy medicines, including circVec AAV gene therapy work that uses circular RNA to enhance…
• Cleara BiotechCleara Biotech develops peptide-based therapies that selectively eliminate p53-impaired cancer cells; products include lead development…
• HealxHealx builds AI-driven drug discovery and development tools and therapies for rare disease patients, applying AI across discovery,…
• OncolinesOncolines provides precision medicine services in oncology and cancer immunotherapy, offering cell‑based assays, profiling platforms,…
• NTrans TechnologiesNTrans Technologies develops a non-viral delivery platform for cell and gene therapies, providing modular delivery solutions for…
• STORM TherapeuticsSTORM Therapeutics develops small molecule inhibitors of RNA-modifying enzymes, including STC-15, a METTL3 inhibitor in clinical…
• ATXA TherapeuticsATXA Therapeutics develops selective small-molecule thromboxane receptor (TP) antagonists, including lead candidate NTP42, to treat…
• ORCA TherapeuticsORCA Therapeutics develops oncolytic virus immunotherapies for prostate cancer, producing lead candidate ORCA-010 for treatment‑naive…